Clinical Trial Update: INSIGHT-PCa: MRI- and PHI-Guided Risk-Adapted Strategy for Prostate Cancer Diagnosis [NA]

View source ↗

Summary

A clinical trial to test an MRI- and PHI-guided risk-adapted diagnostic strategy for detecting prostate cancer; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: In Gab Jeong, MD | Conditions: Prostate Cancer (Diagnosis), Prostate Cancer | NA | Status: RECRUITING